Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IIOngoingNov 8, 2023Gynazole-1Incorrect Product Formulation: Hydrophilic Colloidal Silica was used to manufacture the product rather than Hydrophobic Colloidal Silica as required by the manufacturing...Padagis US LLC · D-0081-2024Class IIITerminatedNov 8, 2023Opium TinctureSubpotent DrugEdenbridge Pharmaceuticals, LLC · D-0080-2024Class IICompletedNov 8, 2023TUMS AntacidPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC · D-0079-2024Class IICompletedNov 8, 2023TUMS AntacidPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC · D-0078-2024Class IICompletedNov 8, 2023TUMS AntacidPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC · D-0077-2024Class IICompletedNov 8, 2023TUMS AntacidPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC · D-0076-2024Class IICompletedNov 8, 2023TUMS AntacidPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC · D-0075-2024Class IICompletedNov 8, 2023TUMS AntacidPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC · D-0074-2024Class IICompletedNov 8, 2023TUMS AntacidPresence of Foreign Substance: The foreign material is primarily comprised of glass mineral wool.GlaxoSmithKline Consumer Healthcare Holdings LLC · D-0073-2024Class IIITerminatedNov 1, 2023VANCOmycin HCI PFLabeling: Not Elsewhere ClassifiedDenver Solutions, LLC DBA Leiters Health · D-0072-2024Class IIITerminatedNov 1, 2023VANCOmycin HCI PFLabeling: Not Elsewhere ClassifiedDenver Solutions, LLC DBA Leiters Health · D-0071-2024Class IIITerminatedNov 1, 2023Oxytocin syntheticLabeling: Not Elsewhere ClassifiedDenver Solutions, LLC DBA Leiters Health · D-0070-2024Class IITerminatedNov 1, 2023Restore Sinus SprayMicrobial contamination of Non-Sterile ProductsBiomic Sciences, LLC dba ION Intelligence of Nature · D-0069-2024Class IITerminatedNov 1, 2023ION* Sinus Support Nasal SprayMicrobial contamination of Non-Sterile ProductsBiomic Sciences, LLC dba ION Intelligence of Nature · D-0068-2024Class ITerminatedNov 1, 2023ION*Sinus SprayMicrobial contamination of Non-Sterile ProductsBiomic Sciences, LLC dba ION Intelligence of Nature · D-0067-2024Class IIIOngoingNov 1, 2023Methotrexate TabletsFailed Tablet/Capsule Specifications: Tablets were observed to have an unsmooth surface with two tablets demonstrating illegible tablet identification and scoring.West-Ward Columbus Inc · D-0066-2024Class IITerminatedOct 25, 2023Foscarnet Sodium 2.4mg/0.1 mL solution for injectionLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0065-2024Class IITerminatedOct 25, 2023Lidocaine HCL 2% and Oxymetazoline HCl 0.025% Solution for intranasal administrationLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0064-2024Class IITerminatedOct 25, 2023Tropi-PhenLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0063-2024Class IITerminatedOct 25, 2023Lidocaine HCl 4% ophthalmic solutionLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0062-2024Class IITerminatedOct 25, 2023Calcium chloride Solution for Intravenous InjectionLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0061-2024Class IITerminatedOct 25, 2023TPC DropsLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0060-2024Class IITerminatedOct 25, 2023Lidocaine-phenylephrine 1%-1.5% 1mL Single Dose VialLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0059-2024Class IITerminatedOct 25, 2023Moxifloxacin in Balanced Salt Solution 400 mcg/0.4 mLLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0058-2024Class IITerminatedOct 25, 2023Cefuroxime 4mg /0.4 mLLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0057-2024Class IITerminatedOct 25, 2023Moxifloxacin in Balanced Salt SolutionLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0056-2024Class IITerminatedOct 25, 2023Tropi-PhenLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0055-2024Class IITerminatedOct 25, 2023Calcium Gluconate 2.5% solution for inhalationLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0054-2024Class IITerminatedOct 25, 2023Calcium Gluconate Ophthalmic Irrigation Solution 1%Lack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0053-2024Class IITerminatedOct 25, 2023Endophth KitLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0052-2024Class IITerminatedOct 25, 2023Vancomycin 1 MG/0.1 ML Solution for Intraocular InjectionLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0051-2024Class IITerminatedOct 25, 2023Bevacizumab 1.25 MG/0.05 ML Solution for InjectionLack of Assurance of SterilityPine Pharmaceuticals, LLC · D-0050-2024Class ITerminatedOct 25, 2023Betaxolol TabletsPresence of Foreign Tablets/Capsules: There is a potential presence of oxycodone HCl tablets, USP 5 mg in bottles.KVK-Tech, Inc. · D-0049-2024Class IITerminatedOct 25, 2023Doxil (doxorubicin hydrochloride liposome injection) 50 mg in 25 mLCGMP Deviations: Product was exposed to temperatures exceeding the labeled storage conditions during transportation were released by mistake.Baxter Healthcare Corporation · D-0048-2024Class ITerminatedOct 25, 2023Sucralfate Oral SuspensionMicrobial Contamination of Non-Sterile Products: identified as Bacillus cereus.VistaPharm LLC · D-0047-2024Class IOngoingOct 25, 2023TheraBreath for Kids! Oral RinseMicrobial contamination of Non-Sterile Product; presence of yeast identified as Candida parapsilosisChurch & Dwight Inc · D-0046-2024Class IIOngoingOct 25, 2023Certain Over-The-CounterCGMP Deviations: OTC products were stored outside of labeled temperature requirements.Dollar Tree Distribution, Inc. · D-0045-2024Class IIITerminatedOct 25, 2023Bupropion Hydrochloride Extended-Release Tablets USPFailed Dissolution SpecificationsSun Pharmaceutical Industries Inc · D-0044-2024Class IIITerminatedOct 25, 2023MYDRIATIC-4: Tropicamide - Proparacaine - Phenylephrine - Ketorolac Sterile Ophthalmic Solution Drops 1%...Subpotent: Out of Specification result observed for Ketorolac assay levels, below the 90.0-110.0% of label claim.Imprimis NJOF, LLC · D-0043-2024Class ICompletedOct 18, 2023BREXAFEMMECross Contamination with Other Products: Potential cross-contamination of ibrexafungerp citrate drug substance with ezetimibe (a non-antibacterial beta-lactam compound).Scynexis, Inc. · D-0042-2024